long term side effects of glp-1 receptor agonists Long-term Success GLP-1s Hinges on More Than Just a Prescription Frontiers | Exploring the multifaceted
Description
Moreover, -glucosidase inhibitors, insulin, and its analogs have not demonstrated significant associations with cancer risk in current studies
Ongoing clinical and mechanistic studies are expected to expand use of GLP-1 receptor agonists, glucose-dependent insulinotropic polypeptide agonists and other metabolic hormones for the treatment of chronic kidney disease
Luo X, Hu Y, He S, Ye Q, Lv Z, Liu J, Chen X
Targeting beta-cell mass in type 2 diabetes: promise and limitations of new drugs based on incretins
& Fornoni, A
